TECHNOLOGY
Arbitrating innovation: Resolving IP disputes in life sciences
As biotech and AI converge, arbitration is emerging as the preferred forum for complex intellectual property disputes – particularly when the underlying science defies straightforward explanation or analysis. In this exclusive feature, Bernhard Maier, partner and head of arbitration...
At-home brain stimulation ‘prevents major depression relapse’
Up to 85% of people with depression experience relapse during treatment.
However, a new clinical study has found that at-home brain stimulation therapy helped 75% of patients stay depression-free over six months, solving a major gap in mental health care.
The...
Principal Investigators: The fuel of scientific progress
PIs are crucial to maintaining research integrity, says Dekel Faruhi, VP of Product Adoption at Proofig AI.
The path to becoming a Principal Investigator (PI) usually takes over a decade, beginning with undergraduate studies and culminating in the acquisition of...
AI hallucinations are eroding trust in lab tools – but there are solutions
As scientists and researchers seek to integrate AI more deeply into daily lab workflows, tackling the issue of false or misleading information has become a top priority, says Andrew Wyatt, Chief Growth Officer, Sapio Sciences.
AI is increasingly important for...
How an AI powered implant is rewriting neurological care
The frontier of neurology has begun to think for itself.
The claim follows pioneering brain surgery carried out at King Faisal Specialist Hospital and Research Centre (KFSHRC).
In June 2025, surgeons at the centre, in Riyadh, Saudi Arabia, implanted the Middle...
Why life sciences must build Recall Ready systems now
From paracetamol contamination to failing defibrillators, recent recall events show how fragile response mechanisms remain. Pete Gillett, founder of Marketpoint Recall, explores why life sciences firms must modernise recall operations before regulatory, financial and reputational costs spiral further.
In mid‑2025,...
AI: reimagining AI healthcare
The UK can overcome challenges and harness AI to address the immense pressures on the NHS, says Pratik Maroo, Senior Vice President and Head – Healthcare and Life Sciences, Zensar.
The UK Prime Minister’s Plan for Change focuses on how...
Rules of protein stability are a billion years old
The rules required to make proteins stable are much simpler than previously thought, according to new research.
Published in the journal Science, the study has taken an important step towards learning the rules of protein stability, which may help protein...
Spinal cord injuries healed with bioelectricity
A groundbreaking bioelectric implant has restored movement in rats after spinal cord injuries.
The breakthrough offers new hope for an effective treatment for humans suffering from loss of sensation and function due to spinal cord injury.
The implant is developed by...
Stroke AI software hailed as ‘revolutionary’
An AI software platform has tripled the number of stroke patients achieving functional independence, from 16% to 48%, according to a study by the Royal Berkshire Hospital.
Additional data from the largest real-world evaluation of stroke AI imaging showed that...
Scotland’s total body PET scanner
UK’s world-class imaging platform extends to Scotland.
Scotland’s first total-body scanner is in situ at the Royal Infirmary of Edinburgh, meaning the National PET (Positron Emission Tomography) Imaging Platform network is now operational across the whole UK.
It’s part of a...
The UK’s AI Healthcare Revolution
The Plan for Change focuses on how technology will be used to improve public services. For healthcare, in particular, the government is committed to bringing analogue NHS into the digital age. Pratik Maroo, Senior Vice President and Head –...
Green footprint of digital vs. traditional clinical trials compared
The new initiative will collect pharma and CRO data to refine industry carbon measurement of technologies like remote monitoring and eConsent, informing more sustainable trial design.
The Pistoia Alliance, a global, not-for-profit alliance for collaboration in life sciences R&D, is launching the...
The rapid rise of decentralised science
Blockchain and open-access technology are transforming scientific publishing, says Philipp Koellinger, CEO and co-founder of open science firm, DeSci Labs.
For centuries, the way we publish and evaluate scientific research has remained largely unchanged. Researchers submit their work to journals,...
AI’s impact on healthcare reliant on building trust
AI could revolutionise healthcare, but not without experts addressing privacy & security concerns as well as existing concerns over industry medical knowledge and practices.
The use of artificial intelligence (AI) in healthcare is growing rapidly. But while it is already...
Can bioprinting cut infection rates?
3D bioprinting technology offers a promising solution to healthcare infection challenges, says Vidmantas Šakalys, CEO of Vital3D Technologies.
Healthcare-associated infections (HAIs) remain a significant concern in modern medicine, with approximately one in 31 hospital patients in the US experiencing at least...
Biotech trends for 2026: The Digital and AI Revolution
The speed of change in biotech is breathtaking, and looking ahead to 2026, several key trends will shape its future, driven by the integration of digital technologies and advanced analytics, says Kevin Cramer, CEO, Sapio Sciences.
The biotechnology industry is...
AI robotic labs will ‘accelerate’ new treatments for deadly infections
Liverpool is the base for new AI-powered, robotic labs to accelerate development of treatments for deadly diseases, supported by £10m of Innovation Zone funding.
The High Containment Level 3 labs, located at the Liverpool School of Tropical Medicine (LSTM) and...
Aston University installs £1.5m mass spectrometer to study biological membranes
The £1.5m mass spectrometer will enable the study of proteins, lipids and metabolites in cell membranes in exceptional detail.
Aston Institute for Membrane Excellence (AIME) and Aston University College of Health and Life Sciences received a grant of £1.5m from...
Medical device design enters fourth dimension
A new project aims to revolution medical device engineering by incorporating a fourth dimension – time.
The 4D Health Tech initiative addresses a critical gap in medical device design: neglect of time-dependent changes in the human body.
Traditional medical devices fail...
Bacon in Space? Lab-grown fat cells a ’game-changer’ for cultivated meat
Pig fat cell production could transform lab-grown meat development, with rare combination of reliable and stable cell growth.
A source of fat cells from pigs has been developed in the lab, offering scientists and food manufacturers a promising tool for...
World’s first leather made from T-Rex DNA
A unique partnership says it is pioneering a cruelty-free and eco-friendly alternative to luxury leather… using prehistoric DNA.
The collaboration combines genomic engineering, advanced tissue engineering and creativity to produce a sustainable high-quality material engineered from synthesised T-Rex DNA.
The venture...
The crabs that glow to hide in coral
Tiny crabs have evolved to use fluorescence as camouflage in coral reefs.
During a night dive in the Red Sea, Ph.D student Susanne Bähr noticed the strange phenomenon, saying: “I had been working with these crabs for some time, so...
‘Organ-on-a-chip’ alternative to animal testing
Bioengineers at Queen Mary University of London have taken a significant step forward in the development of laboratory-based models of human tissues which may be used as alternatives to animal testing.
The group develops organ-on-a-chip technology in which human cells...
Monmouth Scientific Announces Exclusive Partnership with SKAN to Offer the Pure2 Isolator in the UK
Monmouth Scientific, a leading provider of clean air and containment solutions, is proud to announce a new partnership with SKAN, the global leader in innovative and aseptic processing solutions. Through this collaboration, Monmouth Scientific will be the exclusive distributor...
Danish protein analysis ‘revolutionises’ biopharma impurity control
The requirements for quality assurance of biologics are increasing. A Danish contract laboratory says its database - combined with the company’s measurement tools - can shorten the development time and heighten the quality of biological products.
Since 2007, the contract...
Monmouth Scientific: Revolutionising organoid manufacturing
Monmouth Scientific Class 2 Biological Safety Cabinets enhance sterility and efficiency at Molecular Devices’ new Life Science facility.
Global life science and 3D biology pioneers Molecular Devices has launched a groundbreaking facility in Cardiff, dedicated to research, development and industrial-scale...
Spotting image issues early
Integrating AI image checks as part of the workflow can preserve integrity. Dr Dror Kolodkin-Gal, founder of image integrity software Proofig AI, explores how a proactive approach prior to publishing can help preserve the reputation of academic institutions.
Preserving research...
Setting the stage for AI in the pharma cold chain
AI in the pharma cold chain promises exciting possibilities but achieving these benefits is a marathon. It begins with one critical first step: data standardisation, says Otto Dyberg, Chief Information Officer at Envirotainer.
Imagine a world where AI seamlessly optimises...
The training imperative: upskilling your team for the pharma AI revolution
As leaders in the pharmaceutical industry, we stand at a critical juncture. The integration of artificial intelligence (AI) into our daily operations is not just a trend; it is an immediate necessity says Marina Hickson, managing director, Vivanti.
AI is...
